[1]
Farberg, A., Siegel, J. , Kurley, S., Fitzgerald, A., Prasai, A., Goldberg, M., Ibrahim, S. and Estrada, S. 2023. Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s164. DOI:https://doi.org/10.25251/skin.7.supp.164.